Jack L. Wyszomierski - Mar 10, 2023 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
Director
Signature
/s/ Nina Ayer, Attorney in Fact
Stock symbol
EXEL
Transactions as of
Mar 10, 2023
Transactions value $
-$2,133
Form type
4
Date filed
3/14/2023, 08:22 PM
Previous filing
Jan 11, 2023
Next filing
May 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Options Exercise $252K +40K +13.66% $6.30 333K Mar 10, 2023 Direct F1
transaction EXEL Common Stock Sale -$254K -15.3K -4.6% $16.61 317K Mar 10, 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXEL Option (right to buy) Options Exercise $0 -40K -100% $0.00* 0 Mar 10, 2023 Common Stock 40K $6.30 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 19,575 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 8, 2023.
F3 Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $16.52 to $16.70. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
F4 The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 26, 2016.